These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 16878941)
41. On the interrelationship of mu-OH bridged dimers, trimers, and tetramers of (en)PtII and their Ag+ adducts. Shen WZ; Schnebeck RD; Freisinger E; Lippert B Dalton Trans; 2008 Aug; (30):4044-9. PubMed ID: 18648709 [TBL] [Abstract][Full Text] [Related]
43. Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium. Gibbons GR; Wyrick S; Chaney SG Cancer Res; 1989 Mar; 49(6):1402-7. PubMed ID: 2924297 [TBL] [Abstract][Full Text] [Related]
44. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies. Huo S; Shen S; Liu D; Shi T J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871 [TBL] [Abstract][Full Text] [Related]
45. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4. Cheng H; Huq F; Beale P; Fisher K Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394 [TBL] [Abstract][Full Text] [Related]
46. Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt. Baer J; Harrison R; McAuliffe CA; Zaki A; Sharma HL; Smith AG Int J Appl Radiat Isot; 1985 Mar; 36(3):181-4. PubMed ID: 3888854 [TBL] [Abstract][Full Text] [Related]
47. Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent. Sinisi M; Intini FP; Natile G Inorg Chem; 2012 Sep; 51(18):9694-704. PubMed ID: 22921246 [TBL] [Abstract][Full Text] [Related]
48. The radiation chemistry of some platinum-containing radiosensitizers and related compounds. Butler J; Hoey BM; Swallow AJ Radiat Res; 1985 Apr; 102(1):1-13. PubMed ID: 4039071 [TBL] [Abstract][Full Text] [Related]
49. Different binding to DNA of enantiomeric platinum complexes assessed by inhibition of restriction enzyme activity. Coluccia M; Giordano D; Loseto F; Intini FP; Maresca L; Natile G Anticancer Res; 1989; 9(3):795-8. PubMed ID: 2548438 [TBL] [Abstract][Full Text] [Related]
50. Syntheses and electronic structures of one-electron-oxidized group 10 metal(II)-(disalicylidene)diamine complexes (metal = Ni, Pd, Pt). Shimazaki Y; Yajima T; Tani F; Karasawa S; Fukui K; Naruta Y; Yamauchi O J Am Chem Soc; 2007 Mar; 129(9):2559-68. PubMed ID: 17290991 [TBL] [Abstract][Full Text] [Related]
52. Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions. Legin AA; Jakupec MA; Bokach NA; Tyan MR; Kukushkin VY; Keppler BK J Inorg Biochem; 2014 Apr; 133():33-9. PubMed ID: 24444821 [TBL] [Abstract][Full Text] [Related]
53. NMR and X-ray structural characterization of a cisplatin analogue able to slow down the Pt-N7 rotation of a coordinated guanine base by a billion-fold times: 2,2'-bipiperidine(dimethylmalonato)platinum(II) complex. Intini FP; Cini R; Tamasi G; Hursthouse MB; Natile G Inorg Chem; 2008 Jun; 47(11):4909-17. PubMed ID: 18447326 [TBL] [Abstract][Full Text] [Related]
54. Migration of a cis-(NH3)2PtII moiety along two adenine nucleobases, from N1 to N6, is markedly facilitated by additional PtII entities coordinated to N7. Añorbe MG; Welzel T; Lippert B Inorg Chem; 2007 Oct; 46(20):8222-7. PubMed ID: 17824698 [TBL] [Abstract][Full Text] [Related]
55. Analogues of Cis- and Transplatin with a Rich Solution Chemistry: cis-[PtCl2 (NH3 )(1-MeC-N3)] and trans-[PtI2 (NH3 )(1-MeC-N3)]. Siebel S; Dammann C; Sanz Miguel PJ; Drewello T; Kampf G; Teubner N; Bednarski PJ; Freisinger E; Lippert B Chemistry; 2015 Dec; 21(49):17827-43. PubMed ID: 26493181 [TBL] [Abstract][Full Text] [Related]
56. Realization of SOMO-HOMO level conversion for a TEMPO-dithiolate ligand by coordination to platinum(II). Kusamoto T; Kume S; Nishihara H J Am Chem Soc; 2008 Oct; 130(42):13844-5. PubMed ID: 18821762 [TBL] [Abstract][Full Text] [Related]
57. Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death. González-Vadillo AM; Alvarez-Valdés A; Moneo V; Blanco F; Díaz RG; Carnero A; Navarro-Ranninger C J Inorg Biochem; 2007 Apr; 101(4):551-8. PubMed ID: 17257684 [TBL] [Abstract][Full Text] [Related]
58. Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings. 12. New heteropentanuclear complexes carrying four exocyclic cis-platin-like functionalities as potential bimodal (PDT/cis-platin) anticancer agents. Donzello MP; Viola E; Ercolani C; Fu Z; Futur D; Kadish KM Inorg Chem; 2012 Nov; 51(22):12548-59. PubMed ID: 23121685 [TBL] [Abstract][Full Text] [Related]
59. A bromine analogue of picoplatin: a new substance from the group of platinum-based chemotherapeutics. Pažout R; Maixner J; Hrdá M; Loužilová T; Kačer P Acta Crystallogr C; 2013 Apr; 69(Pt 4):337-9. PubMed ID: 23579700 [TBL] [Abstract][Full Text] [Related]
60. Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)]. Margiotta N; Ranaldo R; Intini FP; Natile G Dalton Trans; 2011 Dec; 40(48):12877-85. PubMed ID: 22064914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]